Grow Therapy lands $150M to expand mental health access
Grow Therapy, a U.S. mental health platform focused on connecting patients with in-network providers, has raised $150 million in a Series D round led by TCV. The company said the new capital will support efforts to reduce friction in accessing care, including improving insurance and employer benefit workflows and expanding product capabilities.
Focus on insurance, EAP handoffs, and documentation
A central part of the company’s strategy is streamlining the “handoff” between EAP (Employee Assistance Program) referrals and traditional insurance-covered therapy—an area that often creates delays and drop-off for patients seeking help. Grow Therapy also plans to invest further in AI notes, using automation to assist clinicians with documentation and reduce administrative burden, a persistent issue across behavioral health practices.
Scale: 220M covered lives and 10M visits
The company reported that its network and payer relationships now represent access for roughly 220 million covered lives. It also said it has facilitated more than 10 million visits on its platform, underscoring rapid growth as demand for mental health services continues to outpace provider availability in many regions.
Why it matters
Behavioral health has remained a priority for employers, insurers, and policymakers, but patients frequently face challenges finding in-network providers, understanding benefits, and completing intake. By combining provider enablement, benefits navigation, and automation tools, Grow Therapy is positioning itself as infrastructure for scaling access—particularly for insured care—rather than as a direct-to-consumer therapy brand alone.
Related
